Australia Grants Stem Cell Line To Disgraced S. Korea Researcher
This article was originally published in PharmAsia News
South Korea's disgraced stem cell scientist has been granted a patent in Australia for a line of cloned human embryo stem cells for research. Hwang Woo-suk was fired by Seoul National University after it was discovered he falsified parts of his groundbreaking research that gained international attention. He is still on trial in South Korea on charges of fraud and violating bioethics laws. The new stem cell line now protected in Australia is the same NT-1 line he worked on, but which was discovered to have been grown from unfertilized eggs, contrary to his claim to have produced the first cloned embryo. (Click here for more
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.